Taking stock of the drug industry, from the lab to the medicine chest

July 16, 2024 Check out STAT+

Sponsored By

By Ed Silverman Pharmalot Columnist, Senior Writer

Anna Moneymaker/Getty Images What to know about Trump VP pick J.D. Vance's health care views and investments Vance has a history of investing in health care companies — and of pursuing health care policies that are sometimes at odds with his party's base. By Rachel Cohrs Zhang and Sarah Owermohle STAT+ | A cancer care startup is making a new bet with payers and providers: only pay if it works Cancer care startup Thyme, which wants to cut costs and improve patient outcomes, raises $95 million as it pushes value-based care. By Mohana Ravindranath Opinion: Addressing the dual epidemics of hepatitis C and opioid use Most new hepatitis C infections occur in people who inject drugs, making opioid addiction treatment centers a strategic place to provide hep C treatment. By Sara Lorenz Taki and Lipi Roy

More around STAT

Check out more exclusive coverage with a STAT+ subscription Read premium in-depth biotech, pharma, policy, and life science coverage and analysis with all of our STAT+ articles.

---

Enjoying Pharmalot? Tell us about your experience Continue reading the latest health & science news with the STAT app Download on the App Store or get it on Google Play

STAT, 1 Exchange Place, Boston, MA ©2024, All Rights Reserved. I no longer wish to receive STAT emails

Update Newsletter Preferences     •    Contact Us     •    Advertise with Us     •    View in Browser